NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹4,466 Cr | ₹3,292 Cr | ₹2,667 Cr | ₹2,568 Cr | ₹2,239 Cr |
What is the latest Profit & Loss Account Balance ratio of NATCO PHARMA ?
Year | Profit & Loss Account Balance |
---|---|
Mar2024 | ₹4,466 Cr |
Mar2023 | ₹3,292 Cr |
Mar2022 | ₹2,667 Cr |
Mar2021 | ₹2,568 Cr |
Mar2020 | ₹2,239 Cr |
How is Profit & Loss Account Balance of NATCO PHARMA Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2024 | ₹4,466 Cr | 35.64 | |
Mar2023 | ₹3,292 Cr | 23.46 | |
Mar2022 | ₹2,667 Cr | 3.83 | |
Mar2021 | ₹2,568 Cr | 14.70 | |
Mar2020 | ₹2,239 Cr | - |
Compare Profit & Loss Account Balance of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹17,436.3 Cr | 10.2% | 13.4% | -23.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,788.0 Cr | -0.6% | 0.8% | 10.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,283.0 Cr | 3.1% | 3.8% | 49.2% | Stock Analytics | |
CIPLA | ₹121,853.0 Cr | 0.4% | 2.5% | 1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,914.0 Cr | -0.2% | 6.4% | 20.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,932.0 Cr | -0.6% | 3.3% | 0.1% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 10.2% |
13.4% |
-23.1% |
SENSEX | -0.6% |
3.1% |
5.3% |
You may also like the below Video Courses